Fludarabine exposure predicts outcome after CD19 CAR T-cell therapy in children and young adults with acute leukemia
Linde Dekker(Princess Máxima Center), Stefan Nierkens(Utrecht University), Yilin Jiang(Princess Máxima Center), Josef Vormoor(University Medical Center Utrecht), Kim C. M. van der Elst(University Medical Center Utrecht), Henk Visscher(Princess Máxima Center), Harm van Tinteren(Princess Máxima Center), Friso Calkoen(Princess Máxima Center), Rob Pieters(Princess Máxima Center), A. Laura Nijstad(Erasmus MC - Sophia Children’s Hospital), Caroline A. Lindemans(University Medical Center Utrecht), Saskia R Veldkamp(University of Amsterdam), Rick Admiraal(NHS Blood and Transplant), Hilly Blok(Princess Máxima Center), Marieke Van Der Vlugt(Princess Máxima Center), Marc Bierings(University Medical Center Utrecht), Peter M. Hoogerbrugge(Helios Klinikum Emil von Behring), Coco de Koning(University Medical Center Utrecht), Maike Spoon(Princess Máxima Center), Britta Vormoor(Princess Máxima Center), Alwin D. R. Huitema(The Netherlands Cancer Institute)
Cited by 89
Related Papers
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration
|Journal of Clinical Oncology|2015|1k
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
|The Lancet Oncology|2009|932